BioStem Technologies, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BioStem Technologies, Inc. (BSEM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.31 million shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-18
- BioStem Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.31M shares, a 8934.07% increase year-over-year.
- BioStem Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 58.80K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2026-06-30 | 5.31M shares S-1 · filed 2026-09-18 | 6.24M shares S-1 · filed 2026-09-18 | |
| 2025-12-31 | 6.67M shares S-1 · filed 2026-09-18 | ||
| 2025-06-30 | 58.80K shares S-1 · filed 2026-09-18 | 51.37K shares S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |